Showing results (71-80 of 102) with videos related to

Sort By:
Pageof 11
Archives of Toxicology|June 12, 2014
Internal threshold of toxicological concern values: enabling route-to-route extrapolationFalko Partosch, Hans Mielke, Ralf Stahlmann, et al.
The Journal of Biological Chemistry|June 15, 2011
Curcumin modulates nuclear factor kappaB (NF-kappaB)-mediated inflammation in human tenocytes in vitro: role of the phosphatidylinositol 3-kinase/Akt pathwayConstanze Buhrmann, Ali Mobasheri, Franziska Busch, et al.
Drugs & Aging|November 28, 2012
Ophthalmic drugs as part of polypharmacy in nursing home residents with glaucomaMatthias Huber, Marita Kölzsch, Ralf Stahlmann, et al.
Clinical Therapeutics|December 28, 2002
Oral gemifloxacin versus sequential therapy with intravenous ceftriaxone/oral cefuroxime with or without a macrolide in the treatment of patients hospitalized with community-acquired pneumonia: a randomized, open-label, multicenter study of clinical efficacy and tolerabilityHartmut Lode, Thomas M File, Lionel Mandell, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 6, 2012
Epidemiology, microbiology, and treatment considerations for bacterial pneumonia complicating influenzaMark L Metersky, Robert G Masterton, Hartmut Lode, et al.
Toxicology and Applied Pharmacology|March 12, 2010
Classification of sensitizing and irritative potential in a combined in-vitro assayReinhard Wanner, Anna Sonnenburg, Maria Quatchadze, et al.
Archives of Toxicology|November 4, 2010
A physiologically based toxicokinetic modelling approach to predict relevant concentrations for in vitro testingHans Mielke, Lennart T Anger, Markus Schug, et al.
Archives of Toxicology|January 31, 2018
Lymphocyte surface markers and cytokines are suitable for detection and potency assessment of skin-sensitizing chemicals in an in vitro model of allergic contact dermatitis: the LCSA-lyJanna Frombach, Anna Sonnenburg, Björn-Dirk Krapohl, et al.
The Journal of Antimicrobial Chemotherapy|March 5, 2003
Optimizing ceftazidime pharmacodynamics in patients with acute exacerbation of severe chronic bronchitisAnnette Lubasch, Stefan Lück, Hartmut Lode, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 1, 1996
Comparative pharmacokinetics of macrolide antibiotics and concentrations achieved in polymorphonuclear leukocytes and salivaManuel Fassbender, Hartmut Lode, Christoph Schiller, et al.
Pageof 11